Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Reply.

Dieplinger B, Egger M, Haltmayer M, Mueller T, Luft C, Hinterreiter F, Pernerstorfer T.

J Vasc Surg. 2019 May;69(5):1651-1652. doi: 10.1016/j.jvs.2019.01.023. No abstract available.

PMID:
31010528
2.

Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.

Dieplinger B, Egger M, Luft C, Hinterreiter F, Pernerstorfer T, Haltmayer M, Mueller T.

J Vasc Surg. 2018 Aug;68(2):400-407. doi: 10.1016/j.jvs.2017.11.079. Epub 2018 Mar 20.

PMID:
29571622
3.

The heart matters in diabetes: 10-Year outcomes of peripheral artery disease.

Mueller T, Hinterreiter F, Poelz W, Haltmayer M, Dieplinger B.

SAGE Open Med. 2017 Nov 13;5:2050312117740988. doi: 10.1177/2050312117740988. eCollection 2017.

4.

Prognostic Value of Inflammatory and Cardiovascular Biomarkers for Prediction of 90-Day All-Cause Mortality after Acute Ischemic Stroke-Results from the Linz Stroke Unit Study.

Dieplinger B, Bocksrucker C, Egger M, Eggers C, Haltmayer M, Mueller T.

Clin Chem. 2017 Jun;63(6):1101-1109. doi: 10.1373/clinchem.2016.269969. Epub 2017 Mar 27.

5.

Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.

Mueller T, Gegenhuber A, Leitner I, Poelz W, Haltmayer M, Dieplinger B.

Clin Chim Acta. 2016 Dec 1;463:158-164. doi: 10.1016/j.cca.2016.10.034. Epub 2016 Oct 29.

6.

Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients.

Dieplinger B, Egger M, Leitner I, Firlinger F, Poelz W, Lenz K, Haltmayer M, Mueller T.

J Crit Care. 2016 Aug;34:38-45. doi: 10.1016/j.jcrc.2016.03.020. Epub 2016 Mar 30.

7.

Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease.

Mueller T, Hinterreiter F, Poelz W, Haltmayer M, Dieplinger B.

Vasc Med. 2016 Oct;21(5):445-452. Epub 2016 Apr 11.

8.

Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors.

Mueller T, Egger M, Leitner I, Gabriel C, Haltmayer M, Dieplinger B.

Clin Chim Acta. 2016 May 1;456:19-23. doi: 10.1016/j.cca.2016.02.014. Epub 2016 Feb 24.

9.

Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasma.

Dieplinger B, Egger M, Gegenhuber A, Haltmayer M, Mueller T.

Clin Chim Acta. 2015 Dec 7;451(Pt B):310-5. doi: 10.1016/j.cca.2015.10.015. Epub 2015 Oct 21.

10.

Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session.

Mueller T, Gegenhuber A, Kronabethleitner G, Leitner I, Haltmayer M, Dieplinger B.

Clin Biochem. 2015 Nov;48(16-17):1163-6. doi: 10.1016/j.clinbiochem.2015.07.031. Epub 2015 Jul 29.

11.

Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.

Mueller T, Leitner I, Egger M, Haltmayer M, Dieplinger B.

Clin Chim Acta. 2015 May 20;445:155-60. doi: 10.1016/j.cca.2015.03.033. Epub 2015 Apr 4.

12.

Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.

Dieplinger B, Egger M, Haltmayer M, Kleber ME, Scharnagl H, Silbernagel G, de Boer RA, Maerz W, Mueller T.

Clin Chem. 2014 Mar;60(3):530-40. doi: 10.1373/clinchem.2013.209858. Epub 2014 Jan 8.

13.

Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes.

Mueller T, Hinterreiter F, Luft C, Poelz W, Haltmayer M, Dieplinger B.

J Vasc Surg. 2014 May;59(5):1291-9. doi: 10.1016/j.jvs.2013.11.063. Epub 2014 Jan 3.

14.

Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma.

Dieplinger B, Egger M, Gabriel C, Poelz W, Morandell E, Seeber B, Kronenberg F, Haltmayer M, Mueller T, Dieplinger H.

Clin Chim Acta. 2013 Oct 21;425:236-41. doi: 10.1016/j.cca.2013.08.016. Epub 2013 Aug 24.

15.

Comparison of plasma concentrations of soluble ST2 measured by three different commercially available assays: the MBL ST2 assay, the Presage ST2 assay, and the R&D ST2 assay.

Mueller T, Zimmermann M, Dieplinger B, Ankersmit HJ, Haltmayer M.

Clin Chim Acta. 2012 Oct 9;413(19-20):1493-4. doi: 10.1016/j.cca.2012.06.021. Epub 2012 Jun 20. No abstract available.

PMID:
22743282
16.

Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium.

Wassel CL, Lamina C, Nambi V, Coassin S, Mukamal KJ, Ganesh SK, Jacobs DR Jr, Franceschini N, Papanicolaou GJ, Gibson Q, Yanek LR, van der Harst P, Ferguson JF, Crawford DC, Waite LL, Allison MA, Criqui MH, McDermott MM, Mehra R, Cupples LA, Hwang SJ, Redline S, Kaplan RC, Heiss G, Rotter JI, Boerwinkle E, Taylor HA, Eraso LH, Haun M, Li M, Meisinger C, O'Connell JR, Shuldiner AR, Tybjærg-Hansen A, Frikke-Schmidt R, Kollerits B, Rantner B, Dieplinger B, Stadler M, Mueller T, Haltmayer M, Klein-Weigel P, Summerer M, Wichmann HE, Asselbergs FW, Navis G, Mateo Leach I, Brown-Gentry K, Goodloe R, Assimes TL, Becker DM, Cooke JP, Absher DM, Olin JW, Mitchell BD, Reilly MP, Mohler ER 3rd, North KE, Reiner AP, Kronenberg F, Murabito JM.

Atherosclerosis. 2012 May;222(1):138-47. doi: 10.1016/j.atherosclerosis.2012.01.039. Epub 2012 Feb 2.

17.

Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies.

Murabito JM, White CC, Kavousi M, Sun YV, Feitosa MF, Nambi V, Lamina C, Schillert A, Coassin S, Bis JC, Broer L, Crawford DC, Franceschini N, Frikke-Schmidt R, Haun M, Holewijn S, Huffman JE, Hwang SJ, Kiechl S, Kollerits B, Montasser ME, Nolte IM, Rudock ME, Senft A, Teumer A, van der Harst P, Vitart V, Waite LL, Wood AR, Wassel CL, Absher DM, Allison MA, Amin N, Arnold A, Asselbergs FW, Aulchenko Y, Bandinelli S, Barbalic M, Boban M, Brown-Gentry K, Couper DJ, Criqui MH, Dehghan A, den Heijer M, Dieplinger B, Ding J, Dörr M, Espinola-Klein C, Felix SB, Ferrucci L, Folsom AR, Fraedrich G, Gibson Q, Goodloe R, Gunjaca G, Haltmayer M, Heiss G, Hofman A, Kieback A, Kiemeney LA, Kolcic I, Kullo IJ, Kritchevsky SB, Lackner KJ, Li X, Lieb W, Lohman K, Meisinger C, Melzer D, Mohler ER 3rd, Mudnic I, Mueller T, Navis G, Oberhollenzer F, Olin JW, O'Connell J, O'Donnell CJ, Palmas W, Penninx BW, Petersmann A, Polasek O, Psaty BM, Rantner B, Rice K, Rivadeneira F, Rotter JI, Seldenrijk A, Stadler M, Summerer M, Tanaka T, Tybjaerg-Hansen A, Uitterlinden AG, van Gilst WH, Vermeulen SH, Wild SH, Wild PS, Willeit J, Zeller T, Zemunik T, Zgaga L, Assimes TL, Blankenberg S, Boerwinkle E, Campbell H, Cooke JP, de Graaf J, Herrington D, Kardia SL, Mitchell BD, Murray A, Münzel T, Newman AB, Oostra BA, Rudan I, Shuldiner AR, Snieder H, van Duijn CM, Völker U, Wright AF, Wichmann HE, Wilson JF, Witteman JC, Liu Y, Hayward C, Borecki IB, Ziegler A, North KE, Cupples LA, Kronenberg F.

Circ Cardiovasc Genet. 2012 Feb 1;5(1):100-12. doi: 10.1161/CIRCGENETICS.111.961292. Epub 2011 Dec 23.

18.

Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) study.

Dieplinger B, Egger M, Koehler W, Firlinger F, Poelz W, Lenz K, Haltmayer M, Mueller T.

Clin Chim Acta. 2012 Mar 22;413(5-6):587-93. doi: 10.1016/j.cca.2011.11.028. Epub 2011 Dec 6.

PMID:
22155704
19.

Proguanylin and prouroguanylin--assay evaluation and clinical analyte characterization.

Kaar G, Dieplinger B, Gabriel C, Haltmayer M, Mueller T.

Clin Chim Acta. 2011 Nov 20;412(23-24):2277-83. doi: 10.1016/j.cca.2011.08.016. Epub 2011 Aug 24.

PMID:
21888901
20.

Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females.

Dieplinger B, Egger M, Poelz W, Gabriel C, Haltmayer M, Mueller T.

Clin Chem Lab Med. 2011 Sep;49(9):1515-8. doi: 10.1515/CCLM.2011.239. Epub 2011 Jun 10.

PMID:
21663467
21.

Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.

Gretarsdottir S, Baas AF, Thorleifsson G, Holm H, den Heijer M, de Vries JP, Kranendonk SE, Zeebregts CJ, van Sterkenburg SM, Geelkerken RH, van Rij AM, Williams MJ, Boll AP, Kostic JP, Jonasdottir A, Jonasdottir A, Walters GB, Masson G, Sulem P, Saemundsdottir J, Mouy M, Magnusson KP, Tromp G, Elmore JR, Sakalihasan N, Limet R, Defraigne JO, Ferrell RE, Ronkainen A, Ruigrok YM, Wijmenga C, Grobbee DE, Shah SH, Granger CB, Quyyumi AA, Vaccarino V, Patel RS, Zafari AM, Levey AI, Austin H, Girelli D, Pignatti PF, Olivieri O, Martinelli N, Malerba G, Trabetti E, Becker LC, Becker DM, Reilly MP, Rader DJ, Mueller T, Dieplinger B, Haltmayer M, Urbonavicius S, Lindblad B, Gottsäter A, Gaetani E, Pola R, Wells P, Rodger M, Forgie M, Langlois N, Corral J, Vicente V, Fontcuberta J, España F, Grarup N, Jørgensen T, Witte DR, Hansen T, Pedersen O, Aben KK, de Graaf J, Holewijn S, Folkersen L, Franco-Cereceda A, Eriksson P, Collier DA, Stefansson H, Steinthorsdottir V, Rafnar T, Valdimarsson EM, Magnadottir HB, Sveinbjornsdottir S, Olafsson I, Magnusson MK, Palmason R, Haraldsdottir V, Andersen K, Onundarson PT, Thorgeirsson G, Kiemeney LA, Powell JT, Carey DJ, Kuivaniemi H, Lindholt JS, Jones GT, Kong A, Blankensteijn JD, Matthiasson SE, Thorsteinsdottir U, Stefansson K.

Nat Genet. 2010 Aug;42(8):692-7. doi: 10.1038/ng.622. Epub 2010 Jul 11.

22.

Long-term stability of soluble ST2 in frozen plasma samples.

Dieplinger B, Egger M, Poelz W, Haltmayer M, Mueller T.

Clin Biochem. 2010 Sep;43(13-14):1169-70. doi: 10.1016/j.clinbiochem.2010.05.019. Epub 2010 Jun 8.

PMID:
20534378
23.

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.

Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, Gieger C, Rawal R, Mangino M, Prokopenko I, Mägi R, Keskitalo K, Gudjonsdottir IH, Gretarsdottir S, Stefansson H, Thompson JR, Aulchenko YS, Nelis M, Aben KK, den Heijer M, Dirksen A, Ashraf H, Soranzo N, Valdes AM, Steves C, Uitterlinden AG, Hofman A, Tönjes A, Kovacs P, Hottenga JJ, Willemsen G, Vogelzangs N, Döring A, Dahmen N, Nitz B, Pergadia ML, Saez B, De Diego V, Lezcano V, Garcia-Prats MD, Ripatti S, Perola M, Kettunen J, Hartikainen AL, Pouta A, Laitinen J, Isohanni M, Huei-Yi S, Allen M, Krestyaninova M, Hall AS, Jones GT, van Rij AM, Mueller T, Dieplinger B, Haltmayer M, Jonsson S, Matthiasson SE, Oskarsson H, Tyrfingsson T, Kiemeney LA, Mayordomo JI, Lindholt JS, Pedersen JH, Franklin WA, Wolf H, Montgomery GW, Heath AC, Martin NG, Madden PA, Giegling I, Rujescu D, Järvelin MR, Salomaa V, Stumvoll M, Spector TD, Wichmann HE, Metspalu A, Samani NJ, Penninx BW, Oostra BA, Boomsma DI, Tiemeier H, van Duijn CM, Kaprio J, Gulcher JR; ENGAGE Consortium, McCarthy MI, Peltonen L, Thorsteinsdottir U, Stefansson K.

Nat Genet. 2010 May;42(5):448-53. doi: 10.1038/ng.573. Epub 2010 Apr 25.

24.

Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department.

Dieplinger B, Gegenhuber A, Kaar G, Poelz W, Haltmayer M, Mueller T.

Clin Biochem. 2010 Jun;43(9):714-9. doi: 10.1016/j.clinbiochem.2010.02.002. Epub 2010 Feb 11.

PMID:
20153308
25.

Pregnancy-associated plasma protein-A as a marker for long-term mortality in patients with peripheral atherosclerosis: inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Dieplinger B, Forstner T, Poelz W, Haltmayer M.

Clin Chem Lab Med. 2010 Apr;48(4):537-42. doi: 10.1515/CCLM.2010.103.

PMID:
20148724
26.

Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements.

Cadamuro J, Dieplinger B, Felder T, Kedenko I, Mueller T, Haltmayer M, Patsch W, Oberkofler H.

Eur J Clin Pharmacol. 2010 Mar;66(3):253-60. doi: 10.1007/s00228-009-0768-7. Epub 2009 Dec 18.

PMID:
20020283
27.

Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay.

Dieplinger B, Januzzi JL Jr, Steinmair M, Gabriel C, Poelz W, Haltmayer M, Mueller T.

Clin Chim Acta. 2009 Nov;409(1-2):33-40. doi: 10.1016/j.cca.2009.08.010. Epub 2009 Aug 20.

PMID:
19699192
28.

Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study.

Dieplinger B, Haltmayer M, Poelz W, Mueller T.

Clin Chim Acta. 2009 Oct;408(1-2):87-91. doi: 10.1016/j.cca.2009.07.014. Epub 2009 Jul 30.

PMID:
19646980
29.

Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease.

Gnewuch C, Liebisch G, Langmann T, Dieplinger B, Mueller T, Haltmayer M, Dieplinger H, Zahn A, Stremmel W, Rogler G, Schmitz G.

World J Gastroenterol. 2009 Jul 7;15(25):3134-41.

30.

Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath.

Dieplinger B, Gegenhuber A, Haltmayer M, Mueller T.

Heart. 2009 Sep;95(18):1508-13. doi: 10.1136/hrt.2009.170696. Epub 2009 Jun 11.

PMID:
19525245
31.

Prognostic value of increased adiponectin plasma concentrations in patients with acute destabilized heart failure.

Dieplinger B, Gegenhuber A, Poelz W, Haltmayer M, Mueller T.

Clin Biochem. 2009 Jul;42(10-11):1190-3. doi: 10.1016/j.clinbiochem.2009.02.023. Epub 2009 Mar 6.

PMID:
19272369
32.

Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study.

Dieplinger B, Mueller T, Kollerits B, Struck J, Ritz E, von Eckardstein A, Haltmayer M, Kronenberg F; MMKD Study Group.

Kidney Int. 2009 Feb;75(4):408-14. doi: 10.1038/ki.2008.560. Epub 2008 Dec 3.

33.

Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.

Dieplinger B, Gegenhuber A, Struck J, Poelz W, Langsteger W, Haltmayer M, Mueller T.

Clin Chim Acta. 2009 Feb;400(1-2):91-6. doi: 10.1016/j.cca.2008.10.012. Epub 2008 Oct 29.

PMID:
19000665
34.

Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study.

Mueller T, Dieplinger B, Poelz W, Endler G, Wagner OF, Haltmayer M.

Clin Chem. 2009 Jan;55(1):68-77. doi: 10.1373/clinchem.2008.108753. Epub 2008 Nov 6.

35.

Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease.

Mueller T, Dieplinger B, Poelz W, Haltmayer M.

Clin Appl Thromb Hemost. 2009 Dec;15(6):652-9. doi: 10.1177/1076029608322547. Epub 2008 Sep 19.

PMID:
18805846
36.

Influence of hydroxyethyl starch (6% HES 130/0.4) administration on hematology and clinical chemistry parameters.

Mueller T, Schimetta W, Dieplinger B, Loeffler P, Rehm M, Kreimeier U, Poelz W, Haltmayer M.

Clin Chem Lab Med. 2008;46(4):558-62. doi: 10.1515/CCLM.2008.107.

PMID:
18605936
37.

The K121Q polymorphism of ENPP1 and peripheral arterial disease.

Eller P, Schgoer W, Mueller T, Tancevski I, Demetz E, Duwensee K, Ritsch A, Haltmayer M, Patsch JR.

Heart Vessels. 2008 Mar;23(2):104-7. doi: 10.1007/s00380-007-1014-9. Epub 2008 Apr 4.

PMID:
18389334
38.

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, Saemundsdottir J, Olafsdottir O, Gudmundsson LJ, Bjornsdottir G, Kristjansson K, Skuladottir H, Isaksson HJ, Gudbjartsson T, Jones GT, Mueller T, Gottsäter A, Flex A, Aben KKH, de Vegt F, Mulders PFA, Isla D, Vidal MJ, Asin L, Saez B, Murillo L, Blondal T, Kolbeinsson H, Stefansson JG, Hansdottir I, Runarsdottir V, Pola R, Lindblad B, van Rij AM, Dieplinger B, Haltmayer M, Mayordomo JI, Kiemeney LA, Matthiasson SE, Oskarsson H, Tyrfingsson T, Gudbjartsson DF, Gulcher JR, Jonsson S, Thorsteinsdottir U, Kong A, Stefansson K.

Nature. 2008 Apr 3;452(7187):638-642. doi: 10.1038/nature06846.

39.

Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure.

Mueller T, Dieplinger B, Gegenhuber A, Poelz W, Pacher R, Haltmayer M.

Clin Chem. 2008 Apr;54(4):752-6. doi: 10.1373/clinchem.2007.096560.

40.

The MTP -493TT genotype is associated with peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) Study.

Schgoer W, Eller P, Mueller T, Tancevski I, Wehinger A, Ulmer H, Sandhofer A, Ritsch A, Haltmayer M, Patsch JR.

Clin Biochem. 2008 Jun;41(9):712-6. doi: 10.1016/j.clinbiochem.2008.02.007. Epub 2008 Feb 21.

PMID:
18325332
41.

Scavenger receptor class B type I polymorphisms and peripheral arterial disease.

Ritsch A, Sonderegger G, Sandhofer A, Stanzl U, Tancevski I, Eller P, Schgoer W, Wehinger A, Mueller T, Haltmayer M, Patsch JR.

Metabolism. 2007 Aug;56(8):1135-41. Erratum in: Metabolism. 2007 Nov;56(11):1599. Sonderegger, Gudron [corrected to Sonderegger, Gudrun]; Stanzl, Ursala [corrected to Stanzl, Ursula]; Patsch, Joseph R [corrected to Patsch, Josef R].

PMID:
17618962
42.

Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis.

Schgoer W, Mueller T, Jauhiainen M, Wehinger A, Gander R, Tancevski I, Salzmann K, Eller P, Ritsch A, Haltmayer M, Ehnholm C, Patsch JR, Foeger B.

Atherosclerosis. 2008 Jan;196(1):219-26. Epub 2007 Jun 5.

PMID:
17553507
43.

Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease.

Dieplinger B, Lingenhel A, Baumgartner N, Poelz W, Dieplinger H, Haltmayer M, Kronenberg F, Mueller T.

Clin Chem. 2007 Jul;53(7):1298-305. Epub 2007 May 24.

44.
45.
46.

Association of adiponectin and amino terminal proBNP in peripheral arterial disease.

Dieplinger B, Poelz W, Haltmayer M, Mueller T.

Clin Chim Acta. 2007 Feb;377(1-2):192-7. Epub 2006 Sep 30.

PMID:
17112494
47.

Natriuretic peptide measurements as part of the diagnostic work-up in pleural effusions: an emerging concept?

Mueller T, Haltmayer M.

Eur Respir J. 2006 Jul;28(1):7-9. No abstract available.

48.

Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease.

Dieplinger B, Poelz W, Haltmayer M, Mueller T.

Clin Chem Lab Med. 2006;44(7):830-3.

PMID:
16776628
49.
50.

B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.

Gegenhuber A, Mueller T, Dieplinger B, Poelz W, Pacher R, Haltmayer M.

Clin Chim Acta. 2006 Aug;370(1-2):174-9. Epub 2006 Mar 6.

PMID:
16600203

Supplemental Content

Loading ...
Support Center